EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc. (“Octant” or the “Company”), a next-generation, data-driven therapeutics company developing programmable biology and chemistry to build precision ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a synthetic biology drug discovery company designing small molecule, multi-target drug leads for multifactorial diseases announced that it has raised ...
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the ...
Octant doubles its initial investment in Zymergen’s Automation Technology to significantly increase the scale and throughput of its drug discovery platform EMERYVILLE, Calif., July 14, 2022 (GLOBE ...
“We have been working with Mark for over a year as a Board Member and are thrilled to share that he’s now working with us day-to-day,” said Sri Kosuri, CEO of Octant. “Mark’s unique experience and ...
Many of today’s most trusted drugs are so notorious for their wide range of potentially serious adverse reactions, they are known in the business as “dirty drugs.” Synthetic biology company Octant Bio ...
Octant Bio set out on a journey to show that the convergence of synthetic biology, chemistry, and computational techniques could lead to new drugs for patients. That destination is still distant, but ...
Octant Inc. has received a $4.9 million grant from the Gates Foundation to support a new therapeutics program focused on human papillomavirus (HPV)-related cancers. The initiative will develop ...
RBC Capital Markets, Canaccord and FirstEnergy Capital are involved in the fundraising effort for a company headed by Richard Schmitt, former chief executive of Africa Oil, Black Marlin and Wentworth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results